Net Loss Per Share

6 Months Ended

Jun. 30, 2016

3. NET LOSS PER SHARE

Basic and diluted net loss per share have been computed by dividing the net loss by the weighted-average number of common shares outstanding during the period, without consideration of common share equivalents as their effect would have been antidilutive.

The following tables set forth the computation of the Company’s basic and diluted net loss per share (in thousands, except shares and per share data):

	Three Months Ended June 30,						Six Months Ended June 30,
	2016			2015			2016			2015
Numerator:
Net loss attributable to CareDx, Inc.	$	(10,470	)	$	(3,185	)	$	(20,223	)	$	(5,457	)
Denominator:
Weighted-average shares used to compute basic and diluted net loss per share attributable to CareDx, Inc.		13,568,120			11,835,405			12,768,913			11,824,993
Net loss per share attributable to CareDx, Inc.:
Basic and diluted	$	(0.77	)	$	(0.27	)	$	(1.58	)	$	(0.46	)

The following potentially dilutive securities have been excluded from diluted net loss per share, because their effect would be antidilutive:

	Three Months Ended June 30,				Six Months Ended June 30,
	2016		2015		2016		2015
Shares of common stock subject to outstanding options		1,842,110		1,515,154		1,842,110		1,515,154
Shares of common stock subject to outstanding common stock warrants		3,279,157		576,096		3,279,157		576,096
Restricted stock units		285,445		112,800		285,445		112,800
Total common stock equivalents		5,406,712		2,204,050		5,406,712		2,204,050

The Company issued 2,959,300 shares of preferred stock pursuant to the Private Placement and Subsequent Financing, which were completed on April 14, 2016 and June 15, 2016, respectively. All of the preferred stock was converted to common stock following receipt of the Requisite Stockholder Approval on June 16, 2016. As of June 30, 2016, there was no preferred stock outstanding.